Tissue Regenix Group PLC (LSE:TRX) - Overview

Stock Report

Tissue Regenix Group PLC TRX

Last Price
GBX17.25

Day Change
0.00|0.00%

As of 02/12/2016
08:20:58 GMT | GBX
Minimum 15 Minutes Delay.

Last Close17.25p
Day Range17.19 - 17.19
Mkt Cap131.10Mil
52-Wk Range12.70 - 22.50
Yield %0.00
ISINGB00B5SGVL29
Volume3,712
P/E-13.58
P/S156.82
P/CF-14.79

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
Tissue Regenix Group PLC-2.82 
FTSE 100 TR GBP-1.21
 
Financials
201420152016
More ...
Income Statement
Turnover0.000.000.82
Operating Profit-6.58-8.37-10.24
Net Profit-5.59-7.58-9.50
Reported EPS-0.88-1.19-1.27
Balance Sheet
Current Assets19.6112.2422.30
Non Current Assets0.470.440.90
Total Assets20.0812.6723.20
Current Liabilities1.101.101.96
Total Liabilities1.101.101.96
Total Equity18.9811.5821.24
Cash Flow
Operating Cash Flow-5.65-8.29-8.88
Net Change in Cash-5.72-8.239.65
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-13.31-1.51--11.42---
2018-10.33-1.30--13.27---

Company Profile

Tissue Regenix Group PLC is engaged in the exploitation of technologies in the field of tissue engineering and regenerative medicine. It develops regenerative products to make replacement of native tissue using biological (human and animal) tissues.
 

Sector

Biotechnology

Market Position

798 of 1865 Companies

Index

FTSE AIM All Share

Outlook

(12/10/2016) "...the company continues in line with our ambitions and expectations, we are confident that our results for the full year will reflect this"

Next Event 31/01/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-11.3013.1416.27
Div Yld (E)0.004.184.36
PEG (E)0.000.360.00
ROCE-47.22206.9680.66
Op Mrgn-1,255.15-17.09-14.86
EPS Grwth0.009.6525.03
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. John Samuel
Chief Executive OfficerMr. Anthony Odell
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.